Comparison of effects on systolic and diastolic left ventricular function of nebivolol versus atenolol in patients with uncomplicated essential hypertension
about
Nebivolol: a novel beta-blocker with nitric oxide-induced vasodilatationA Review of Nebivolol Pharmacology and Clinical EvidenceNebivolol: third-generation beta-blockadeBeta-blockers in the treatment of hypertension: new data, new directions.Heart rate control with adrenergic blockade: clinical outcomes in cardiovascular medicineBeneficial effects of nebivolol in comparison with atenolol on safety and tolerability in essential hypertension.Cost-effectiveness analysis of nebivolol and metoprolol in essential hypertension: a pharmacoeconomic comparison of antihypertensive efficacy of beta blockersClinical and economic aspects of the use of nebivolol in the treatment of elderly patients with heart failureClinical utility of fixed-dose combinations in hypertension: evidence for the potential of nebivolol/valsartan.Medical angioplasty - hope and expectations: an optimistic overview.Acute β-adrenergic blockade increases aortic wave reflection in young men and women: differing mechanisms between sexes.Cardiovascular-related healthcare resource utilization and costs in patients with hypertension switching from metoprolol to nebivolol.Nebivolol: a review.Nebivolol: impact on cardiac and endothelial function and clinical utility.Beta-blockade in the perioperative period: where do we stand after all the trials?A review of the safety and efficacy of nebivolol in the mildly hypertensive patient.Nebivolol for heart failure in the elderly.Hypertension treatment in the Asia-Pacific: the role of and treatment strategies with nebivololNebivolol: pharmacologic profile of an ultraselective, vasodilatory beta1-blocker.Nebivolol in high-risk, obese African Americans with stage 1 hypertension: effects on blood pressure, vascular compliance, and endothelial function.Beta-blockers in the treatment of hypertension: are there clinically relevant differences?Nebivolol and valsartan as a fixed-dose combination for the treatment of hypertension.Fixed-dose combination therapy of nebivolol and valsartan for the treatment of hypertension.Differential Metabolic Effects of Beta-Blockers: an Updated Systematic Review of Nebivolol.Protective effects of nebivolol from oxidative stress to prevent hypertension-related target organ damage.Simultaneous Estimation of Nebivolol Hydrochloride and Valsartan using RP HPLCDevelopment, evaluation, and influence of formulation and process variables on in vitro performance of oral elementary osmotic device of atenolol.Formulation and in vitro evaluation of bilayer tablets of nebivolol hydrochloride and nateglinide for the treatment of diabetes and hypertensionAdding nebivolol to ongoing antihypertensive therapy improves blood pressure and response rates in patients with uncontrolled stage I-II hypertension.Effects of nebivolol on left ventricular function in elderly patients with chronic heart failure: results of the ENECA study.A retrospective study evaluating the tolerability and effectiveness of adjunctive antihypertensive drugs in patients with inadequate response to initial treatment.
P2860
Q24681317-E7C48C2F-10BE-4DFA-8738-2EE44CDF3BC2Q26801287-9E3E76B5-E25A-4ECA-BD1A-81BEC93C492AQ28238369-7FFECB79-E802-4D35-9B01-F2CCF3EEC956Q31149036-541B0D0A-0228-442C-9BB5-1E3979D40619Q33902610-6B9F6F91-6FC4-4D71-BC2B-EBD1818CC287Q34030454-D80E96DF-76B9-479C-BAB7-059AEF2FD447Q34247622-91CFEE08-C034-492A-B090-C0DC33D2930AQ34386568-E47F5B1A-F1AE-48CA-96CD-AADA8162F3D8Q34609451-739D4EFE-4BE4-4A00-B067-6FAA15E2D603Q35610914-FA0812F1-ACB0-484E-B3A9-5EA8B8D35CFAQ35621708-C90E7D09-D4E7-4B68-A04F-B14502FCA93EQ35623864-ACE6B17A-137C-42C8-97A5-0AB06AB86A51Q35753422-03821C91-D992-4C19-97E9-735ECA9A44C8Q35846698-9FB41339-1DF5-484E-A865-2DA938B12447Q36480100-6ED99C63-C20C-4ED6-A7A1-A9F7741C2FE6Q36596852-875F5807-2D1E-4145-A88E-F782006D1391Q36815960-39C3A731-4BBE-4686-B80B-EF5FE386C76BQ36982759-C7E9CAD2-3E05-40B9-ADF1-A9FE4C771EF7Q37033656-B1042204-1012-4259-AC52-B8E7F512EFDAQ37102837-424F0874-A98D-46CA-9C3C-8993A0AC2A8EQ37505881-6A674728-35AF-4496-AFB7-EC1C42ED4D07Q38369464-5B434E4B-FF5D-4DEB-88D3-18A9B77EEF05Q38778217-24F3D108-5FD2-47A0-9EA2-E2B1E679EF58Q38913816-745DA6D6-454B-4AFA-B7F7-32B8BA4821BBQ39157832-36DC2B2F-9F45-4599-8450-0A4BA7D9FCECQ39643542-455F4B56-38F2-4BD9-AC5D-4E27DACA04F1Q40464098-AE7CBFEA-0385-43E0-8956-D648FC12926CQ42150154-78C436A5-D8FC-49B3-B067-F1894C077BF3Q46031238-7CF1F713-AEB4-432C-94D7-D7A4888F5FEDQ46514966-CBF17E35-99A3-41B8-BAD5-0EDF264B5FA9Q55692447-47F07CBF-EC7A-4B72-B258-55656DB7EE41
P2860
Comparison of effects on systolic and diastolic left ventricular function of nebivolol versus atenolol in patients with uncomplicated essential hypertension
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Comparison of effects on systo ...... licated essential hypertension
@ast
Comparison of effects on systo ...... licated essential hypertension
@en
Comparison of effects on systo ...... licated essential hypertension
@nl
type
label
Comparison of effects on systo ...... licated essential hypertension
@ast
Comparison of effects on systo ...... licated essential hypertension
@en
Comparison of effects on systo ...... licated essential hypertension
@nl
prefLabel
Comparison of effects on systo ...... licated essential hypertension
@ast
Comparison of effects on systo ...... licated essential hypertension
@en
Comparison of effects on systo ...... licated essential hypertension
@nl
P2093
P921
P1476
Comparison of effects on systo ...... licated essential hypertension
@en
P2093
Cees A Visser
Gertjan T Sieswerda
P356
10.1016/S0002-9149(03)00645-3
P407
P577
2003-08-01T00:00:00Z